Recent research and activities at Ragon

Investigational HIV Vaccine Regimen Shows Encouraging Results in Non-Human Primates

NEW BRUNSWICK, N.J., – July, 2, 2015 – Johnson & Johnson (NYSE: JNJ) announced Thursday that scientists at Beth Israel Deaconess Medical Center (BIDMC), Crucell Holland B.V, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), and several other collaborators today published results from a preclinical study of an HIV vaccine regimen used […]

Read more
Balazs Awarded NIDA Avenir Award

The National Institute on Drug Abuse (NIDA) recently announced the first recipients of its two newly developed Avenir Award programs for HIV/AIDS and genetics research. The Avenir (meaning “future” in French) Awards support early stage investigators who propose highly innovative studies. The six scientists will each receive up to $300,000 per year for five years […]

Read more
Dendritic Cells of Controllers Recognize, Mount Defense Against HIV

Investigators from Massachusetts General Hospital (MGH) and the Ragon Institute of MGH, MIT and Harvard have added another piece to the puzzle of how a small group of individuals known as elite controllers are able to control HIV infection without drug treatment. In their paper published in the open-access journal PLOS Pathogens, the research team […]

Read more
Ragon Science Day 2015

Jun 10

On June 5, 2015, the Ragon Institute held its second annual Ragon Science Day.   The event featured 34 poster presentations, a thought-provoking panel discussion on “HIV Prevention: Past, Present, and Future” with six experts in the field, and a social hour. Over 150 Ragon members participated in the event.   Click images to enlarge. […]

Read more
Ragon Supports 30th Annual AIDS Walk

Sunday, June 7 marked the 30th annual AIDS Walk Boston & 5K Run, one of the oldest walks of its kind in the country.  About 10,000 people from across New England attended the event which returned to its roots on the Boston Common.   Participants walk for different reasons, but walk together for one common […]

Read more
2014 Ragon Institute Annual Report

The 2014 Ragon Institute Annual Report is now available to view online or download! Learn about the Ragon Institute’s top accomplishments during the year.   2014 Ragon Institute Annual Report [With the interactive plugin above, you can use the menu bar to share, download as a PDF, or expand to full screen.]   If you […]

Read more
Bacterial Communities of Female Genital Tract Have Impact on HIV Risk

Most common bacterial community in healthy South African women may increase presence of T cells targeted by HIV   A team led by researchers from Massachusetts General Hospital (MGH) and the Ragon Institute of MGH, MIT and Harvard has found that the most common bacterial community in the genital tract among healthy South Africa women […]

Read more
Ragon Celebrates Six Years

May 14

Six years of innovation has not dampened the zeal of the researchers and staff of the Ragon Institute.  Just as at the inception of the Institute in 2009, faculty and staff continue to work tirelessly toward the common goal of  developing a vaccine for HIV and have, in the process, established Ragon as a leading […]

Read more
Ragon Participates in 4th Annual Global Health Expo

For the fourth year in a row, the Ragon Institute International Program participated in the Massachusetts General Hospital Global Health Expo, sponsored by the Mass General Center for Global Health.   The event was held Wednesday, May 6 at the MGH main campus and over 40 organizations, representing multiple departments and specialties, were on hand […]

Read more
Seeing the Future of African Science

Between 2005 and 2006, an outbreak of extensively drug resistant tuberculosis (XDR-TB) killed all but one patient at the Church of Scotland Hospital in Tugela Ferry, South Africa. The median survival time following diagnosis was a mere 16 days, and of the patients tested, all were co-infected with HIV. The situation was desperate, the fatality […]

Read more

Sign up for our mailing list.

Donate to Our Work